Des vaccinations infantiles en reflux dans plusieurs pays de l’UE depuis le Covid 

A comprehensive study published on September 17 in The Lancet Regional Health reveals a shifting landscape in public health across the 27 nations of the European Union. While the decades spanning from the 1980s to the pre-pandemic era were characterized by a robust and steady increase in childhood vaccination rates, the period since 2019 has signaled a precarious reversal. Researchers, utilizing data from the World Health Organization (WHO) and UNICEF, analyzed coverage trends for seven core vaccines—diphtheria, tetanus, pertussis, hepatitis B, meningitis B, polio, and pneumococcal disease—over a 44-year timeline. The findings suggest that the hard-won gains in immunity that protected generations of European children are now beginning to erode.

A Historical Context of Immunization in Europe

To understand the gravity of the current decline, one must look at the historical trajectory of European immunization programs. Following the introduction of widespread vaccination initiatives in the late 20th century, European nations achieved what public health experts call "herd immunity" for several dangerous pathogens. These efforts were credited with preventing millions of premature deaths and debilitating complications.

Throughout the 1990s and early 2000s, EU member states synchronized their efforts to reach the WHO-recommended target of 95% coverage for childhood vaccinations. This threshold is considered the "gold standard" because it ensures that even those who cannot be vaccinated—due to medical conditions or age—are protected by the lack of transmission within the community. By 2015, many Western and Northern European countries had successfully surpassed this 95% milestone, effectively marginalizing diseases like measles and polio to the status of rare, imported, or contained cases.

The Pandemic Turning Point: 2019–2024

The study indicates that the turning point for this decline began between 2019 and 2022, a timeframe that correlates directly with the global emergence of the COVID-19 pandemic. While the research authors emphasize that the study was not designed to establish a direct causal link between the pandemic and the decline, the temporal coincidence is stark.

The pandemic introduced unprecedented pressures on healthcare systems. During the height of the crisis, routine medical visits were frequently deprioritized, and in many regions, lockdown measures restricted access to standard immunization clinics. Furthermore, the disruption of supply chains and the redirection of human resources toward COVID-19 management created "catch-up" gaps that many countries have yet to fully address.

However, the pandemic’s impact was not merely logistical. The global health crisis also served as a catalyst for a rise in vaccine hesitancy. The intense public discourse surrounding COVID-19 vaccines, often fueled by misinformation on social media platforms, appears to have had a "spillover effect," casting doubt on the safety and efficacy of traditional childhood vaccines. This erosion of public trust has manifested in lower appointment attendance rates across 16 EU nations.

Statistical Analysis of the Decline

The data provided by the study paints a sobering picture of the geographic spread of this phenomenon. The researchers categorized countries based on the severity of the decline in vaccination coverage:

1. High-Prevalence Declines: In Bulgaria, Cyprus, Ireland, the Netherlands, Romania, and Sweden, immunization rates have dropped across all seven studied vaccine categories.
2. Moderate Declines: Germany and Spain have reported a decline in coverage for five of the seven vaccines.
3. Mixed Trends: France and Italy present a more complex picture, with increases in coverage for four vaccines, but concerning dips in three others.

The most affected vaccines are those targeting meningitis B and polio, which have seen coverage rates drop in 20 EU countries. Hepatitis B immunization has seen a decline in 18 countries, while the combination vaccine for diphtheria, tetanus, and polio has weakened in 17. While measles and rubella coverage has proven slightly more resilient, the overall trend is undeniably downward, creating vulnerabilities in the regional population.

Regional Disparities and Public Health Vulnerability

The study highlights significant disparities between EU member states. Luxembourg and Portugal stand as exceptions to the downward trend, maintaining coverage levels at or above 95% for all seven vaccinations. In contrast, Romania has struggled with coverage rates falling below 80% for several categories.

These disparities are critical because infectious diseases do not respect national borders. In an integrated European market with high levels of travel and migration, a drop in vaccination rates in one country creates a potential reservoir for outbreaks that can quickly spread to neighbors. Public health experts warn that even a 2–3% drop below the 95% target can be enough to trigger a localized outbreak of highly contagious diseases like measles, which has already seen a resurgence in several parts of Europe over the past two years.

Implications for Future Policy

The implications of this decline are profound. The study reminds us that over the past 50 years, global immunization programs have prevented more than 154 million deaths. The primary beneficiaries of these programs have been children. A reduction in these numbers suggests that the current generation of children is becoming increasingly susceptible to diseases that were previously considered "under control."

Public health authorities are now facing the challenge of how to reverse these trends. Potential strategies include:

• Renewed Public Communication: Experts suggest that governments must move beyond simple "fact-based" messaging and address the psychological roots of vaccine hesitancy through targeted, culturally sensitive communication campaigns.
• Accessibility Improvements: For countries where the decline is tied to administrative or systemic issues, there is an urgent need to simplify the vaccination process, perhaps by integrating it more effectively into school health programs or primary care digital portals.
• Strengthening Monitoring Systems: The study advocates for better real-time monitoring of immunization data to allow for rapid intervention before local dips in coverage become entrenched regional trends.

Analysis: The "Vaccine Fatigue" Phenomenon

The current situation is often described by social scientists as "vaccine fatigue." This is not necessarily the same as anti-vaccination sentiment; rather, it is a state of apathy or exhaustion regarding health interventions. Having navigated the intense, polarized environment of the pandemic, many parents have become overwhelmed by the volume of information—and disinformation—available.

Furthermore, the very success of vaccines in the late 20th century has paradoxically contributed to their current decline. Because diseases like polio or diphtheria are no longer common in the public consciousness, the perceived risk of these illnesses has diminished, while the perceived risk of the vaccines themselves—often exaggerated by online communities—has gained a disproportionate amount of attention.

Expert Reaction and Future Outlook

While international health bodies have yet to issue a unified policy response to this specific Lancet study, the findings align with warnings from the European Centre for Disease Prevention and Control (ECDC). The ECDC has long emphasized that maintaining high vaccination coverage is not a one-time achievement but a continuous, resource-intensive process.

Medical professionals are calling for a "back-to-basics" approach to pediatric health. This involves revitalizing the role of the pediatrician as the primary source of truth, ensuring that parents have access to clear, jargon-free information regarding the schedule and necessity of childhood immunizations.

As Europe looks toward the remainder of the decade, the primary goal for health ministers will be to reclaim the ground lost between 2019 and 2024. The study serves as a definitive "wake-up call" that the health of the European population is fragile and dependent on the collective action of its citizens. Without a strategic effort to rebuild confidence and accessibility, the continent risks a return to a era where preventable infectious diseases once again become a common feature of childhood.

The path forward requires a multi-faceted approach involving legislative support, community-level engagement, and the transparent communication of data. As the study concludes, the urgency to prevent the reappearance of these diseases cannot be overstated; the health of future generations depends on the strength of the public health infrastructure maintained today. The 2024 data serves not only as a record of decline but as a baseline for a necessary, systemic recovery.